Will Garvin, shareholder in the firm's Life Sciences industry and co-chair of the firm’s Cannabis practice group, weighs in on the House's recent cannabis legislation in a HBW Insight article, "Historic Cannabis Legislation Passed By House Would Lift US Cannabinoids Business Roadblocks."
William Garvin, an attorney with Buchanan Ingersoll & Rooney PC in Washington, pointed out that even as recently 10 years ago, public polling showed 37% support for legalizing marijuana and neither chamber would consider voting on legislation similar to the MORE Act, Garvin said.
Currently, polling indicates 60% percent support. “I think it really shows you where the nature of the debate is going,” he said.
“It is an historic thing. If it passes one chamber of Congress, you’re halfway there,” Garvin said.